Xuewu Liang

发表

Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups.

Wenfang Xu, Yingjie Zhang, C. Chou, 2017, Bioorganic & medicinal chemistry.

Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.

B. Wang, Wenfang Xu, Yingjie Zhang, 2018, Bioorganic & medicinal chemistry.

Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.

Ping Wu, Yingxia Li, Wenfang Xu, 2016, European journal of medicinal chemistry.

Novel β-dicarbonyl derivatives as inhibitors of aminopeptidase N (APN).

Wenfang Xu, Xiaoguang Li, Chunhua Ma, 2013, Bioorganic & medicinal chemistry letters.

Design, synthesis and preliminary biological evaluation of 4-aminopyrazole derivatives as novel and potent JAKs inhibitors.

B. Wang, Wenfang Xu, Yingjie Zhang, 2016, Bioorganic & medicinal chemistry.

I2-induced cascade cyclization and dearomatization of indoles for the highly efficient synthesis of iodinated and vinylic spiroindolenines

Hong Liu, Yu Zhou, Qi Liu, 2021, Green Chemistry.

Advances on graphene-based nanomaterials for biomedical applications.

Qiuqiong Zhang, Jingde Wu, Jingde Wu, 2018, Materials science & engineering. C, Materials for biological applications.

MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies

Hong Liu, Chenghua Yang, Chunpu Li, 2021, Medicinal research reviews.

Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors.

Hong Liu, Yingjie Zhang, Xuewu Liang, 2019, Future medicinal chemistry.

Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies.

Min Huang, M. Geng, Hong Liu, 2019, Journal of medicinal chemistry.

Design, Synthesis, and Antitumor Evaluation of 4-Amino-(1H)-pyrazole Derivatives as JAKs Inhibitors.

B. Wang, Wenfang Xu, Yingjie Zhang, 2016 .

Discovery of Novel Imidazo[4,5-c]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal Homeostasis.

Yu Zhou, Min Huang, M. Geng, 2022, Journal of medicinal chemistry.

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.

Peng Zhan, Xiao Ding, Ye Tian, 2018, Journal of medicinal chemistry.

JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases.

Wenfang Xu, Yingjie Zhang, J. Zang, 2016, Current drug targets.

Discovery of Novel Pyrrolo[2,3-d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors.

Yu Zhou, Min Huang, M. Geng, 2021, Journal of medicinal chemistry.

Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously.

Yuping Jia, Wenfang Xu, Yingjie Zhang, 2018, Journal of medicinal chemistry.

Development of N-hydroxycinnamamide-based HDAC inhibitors with improved HDAC inhibitory activity and in vitro antitumor activity.

Wenfang Xu, Yingjie Zhang, J. Zang, 2017, Bioorganic & medicinal chemistry.

The new direction of drug development: Degradation of undruggable targets through targeting chimera technology

Xuewu Liang, Hong Liu, Hairu Ren, 2023, Medicinal research reviews.

VEGF signal system: the application of antiangiogenesis.

Fuming Xu, Wenfang Xu, Yingjie Zhang, 2014, Current medicinal chemistry.

Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors

Yu Zhou, Chunpu Li, Yin-chun Ji, 2023, Acta pharmaceutica Sinica. B.

Discovery and Optimization of Novel Nonbile Acid FXR Agonists as Preclinical Candidates for the Treatment of Inflammatory Bowel Disease.

Yu Zhou, Yi Zang, Dong Zhang, 2024, Journal of medicinal chemistry.